In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

During the COVID-19 pandemic, healthcare workers faced several mental health challenges, experiencing repeated exposure to ...

An intervention program that coaches patients in stress management and goal setting, along with a digital app, helped ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

Gene therapies have a lot of potential to improve health outcomes for patients with life-threatening diseases but face a ...

Lindsay Bealor Greenleaf, JD, MBA; Ryann Hill, MPH; Patrick Cooney ...

The campaign for hand eczema is the latest in a number of high-cost campaigns to raise awareness of dermatological conditions ...

Short-term hormone therapy lasting four years initiated within three years of the last menstrual cycle had no long-term ...

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...

President-elect Donald Trump announced last Thursday, Nov. 14, that Kennedy, 70, was his pick to head the Department of ...

In a recent conversation with Greg Baker, CEO of AffirmedRx, the PBM professional outlined the company’s distinct approach in the PBM industry with MHE editors.

Monjuvi is available under an accelerated approval to treat adults with relapsed or refractory diffuse large B-cell lymphoma.